精品国产乱码一区,欧美自拍网站一二,亚洲AV熟女传媒一区二区三区,亚洲在线麻豆

咨詢熱線

15000266580

當(dāng)前位置:首頁 >產(chǎn)品中心>細(xì)胞庫>人正常細(xì)胞>CLHKGR02美國(guó)人糖皮質(zhì)激素受體穩(wěn)定細(xì)胞株

美國(guó)人糖皮質(zhì)激素受體穩(wěn)定細(xì)胞株

簡(jiǎn)要描述:美國(guó)人Glucocorticoid糖皮質(zhì)激素受體穩(wěn)定細(xì)胞株(線粒體表達(dá))
美國(guó)人糖皮質(zhì)激素受體穩(wěn)定細(xì)胞株
美國(guó)PrimCells誘導(dǎo)性穩(wěn)定細(xì)胞株: PrimCells建立的*的誘導(dǎo)性細(xì)胞高效開發(fā)系統(tǒng),能在極短時(shí)間內(nèi)篩選出低泄漏,高誘導(dǎo)性的穩(wěn)定細(xì)胞株,成功開發(fā)出一系列核受體誘導(dǎo)表達(dá)的穩(wěn)定細(xì)胞

  • 產(chǎn)品型號(hào):CLHKGR02
  • 廠商性質(zhì):生產(chǎn)廠家
  • 更新時(shí)間:2025-04-27
  • 訪  問  量:2128

產(chǎn)品分類

Product Category

詳細(xì)介紹

美國(guó)人Glucocorticoid糖皮質(zhì)激素受體穩(wěn)定細(xì)胞株(線粒體表達(dá))

美國(guó)PrimCells誘導(dǎo)性穩(wěn)定細(xì)胞株: PrimCells建立的*的誘導(dǎo)性細(xì)胞高效開發(fā)系統(tǒng),能在極短時(shí)間內(nèi)篩選出低泄漏,高誘導(dǎo)性的穩(wěn)定細(xì)胞株,成功開發(fā)出一系列核受體誘導(dǎo)表達(dá)的穩(wěn)定細(xì)胞株產(chǎn)品,為多家制藥公司研發(fā)部門和科研院所提供產(chǎn)品與服務(wù),廣受用戶好評(píng)。針對(duì)客戶的特定需求,PrimCells亦提供量身定制服務(wù),通過密切的客戶交流和高效的篩選體系,嚴(yán)格保證客戶在3-4周內(nèi)即獲得高質(zhì)量的誘導(dǎo)性穩(wěn)定細(xì)胞株,具有市場(chǎng)其他供應(yīng)商*的時(shí)效性。

美國(guó)人Glucocorticoid糖皮質(zhì)激素受體穩(wěn)定細(xì)胞株(線粒體表達(dá))


Introduction:

Nuclear hormone receptors (NHRs) are a superfamily of transcription factors that function as powerful metabolic regulators to control a variety of systemic processes in physiology. They also play key roles in the pathophysiology of many major disease states, such as diabetes, obesity, inflammation, atherosclerosis and heart failure. To date, this superfamily has provided a rich source of drug design targets and it is continuing to be one of the hottest areas for pharmaceutical research.

PrimCells now provides a comprehensive set of NHR expressing cell lines to the research community. These high-quality, Flag and/or HA-tagged NHR-expressing cell lines aim to facilitate further biochemical and molecular studies of their functions and hence encourage new strategies for drug design.

Glucocorticoids (GCs) are steroid hormones that allow us to cope with environmental and physiological stresses. Although GCs are widely used as anti-inflammatory agents in several clinical areas, long-term use of those steroids causes problems instead. Full achievement of the clinical potential of GCs necessitates limiting the side effects of these drugs.

The lipophilic nature of GCs allows them to readily diffuse into the cells, where they bind to a cytosolic receptor, the Glucocorticoid Recetpor (GR) to exert their mechanism of action. Without ligand binding, GR is predominantly localized in cytoplasm, whereas upon ligand binding it rapidly translocates to nucleus where it can both positively and negatively regulate gene expression. GR belongs to the nuclear receptor superfamily of ligand-activated transcription factors that function as powerful metabolic regulators. Several studies have shown that GR also translocates to the mitochondrial in addition to its nuclear translocation in response to GC treatment. The mitochondrial GR translocation has been shown to be positively correlated with GC-induced apoptosis, although the mechanism is unclear.

The mitochondrial-specific GR (Flag and HA tagged)/HEK293 cell line was created by stable transfection of HEK293 cells with a plasmid expressing Flag and HA tagged GR protein with a mitochondrial localization signal.

美國(guó)人糖皮質(zhì)激素受體穩(wěn)定細(xì)胞株

美國(guó)PrimCells品牌介紹

PrimCells是位于美國(guó)加州圣迭戈的一家專業(yè)致力于細(xì)胞產(chǎn)品研發(fā)和解決方案提供的業(yè)內(nèi)技術(shù)。

公司匯集了*的生物醫(yī)藥技術(shù)專家,獨(dú)立開發(fā)了多項(xiàng)原代細(xì)胞和干細(xì)胞相關(guān)的專有技術(shù)。 公司以“細(xì)胞研究的優(yōu)選擇"為宗旨,自主研發(fā)超過70種創(chuàng)新產(chǎn)品,多個(gè)特種細(xì)胞市場(chǎng)的空白。例如其誘導(dǎo)性表達(dá)細(xì)胞庫和高效3D皮膚培養(yǎng)系統(tǒng),皆為該類產(chǎn)品目前市場(chǎng)上少數(shù)的規(guī)?;?yīng)商。此外,公司以高質(zhì)量的數(shù)據(jù)與快速穩(wěn)定的項(xiàng)目完成時(shí)間,長(zhǎng)期為多家制藥公司提供解決方案,獲得用戶廣泛贊譽(yù)。

PrimCells產(chǎn)品線:

  • 報(bào)告基因干細(xì)胞        2. 原代細(xì)胞(含報(bào)告基因原代細(xì)胞)               3. 誘導(dǎo)性穩(wěn)定細(xì)胞株

4. 人源重組蛋白               5.   創(chuàng)新型培養(yǎng)試劑

PrimCells 解決方案

1.誘導(dǎo)性穩(wěn)定細(xì)胞株開發(fā) 2. 原代細(xì)胞開發(fā) 3. 藥物體外毒理和效能測(cè)試 4. 3D-皮膚培養(yǎng)

PrimCells合作伙伴及客戶:

A.生物制藥公司:輝瑞(Pfizer), 諾華(Novartis), 禮來(Eli2  Lilly),. Amgen, EMD Millipore, Regeneron等公司的毒理和醫(yī)藥研發(fā)部門

B.科研機(jī)構(gòu):冷泉港實(shí)驗(yàn)室,哈佛醫(yī)學(xué)院, 麻省理工(MIT),, UCSF, NYU, Salk, UIUC, USC等

美國(guó)人Glucocorticoid糖皮質(zhì)激素受體穩(wěn)定細(xì)胞株(線粒體表達(dá))















產(chǎn)品咨詢

留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說明:

  • 驗(yàn)證碼:

    請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
聯(lián)系方式

郵箱:xiangfbio@163.com

地址:上海市虹口區(qū)四平路710號(hào)7層

咨詢熱線

400-821-8510

(周一至周日9:00- 19:00)

在線咨詢
  • 掃一掃 微信咨詢

Copyright©2025 上海復(fù)祥生物科技有限公司 All Right Reserved    備案號(hào):滬ICP備10013034號(hào)-2     sitemap.xml
技術(shù)支持:化工儀器網(wǎng)    管理登陸
久久国产精品一区二区三区| 天天综合天天爱天天做| 亚洲午夜精品| 女同亚洲精品一区二区三| 久久99久久精品久久久久久| 久久久国产精品一区二区18禁 | 亚洲中文字幕一区二区| 中文字幕亚洲欧美日韩在线不卡| 激情综合色五月丁香六月欧美| 久久青青草原一区二区| 色一欲一性一乱—区二区三区| xxx视频| 精品伊人久久久大香线蕉下载| 久久综合九色综合欧美98| 婷婷色爱区综合五月激情韩国| 剑河县| 国产人妖视频| 成人色| 欧美精品一区在线| 伊人精品视频| 亚洲精品思思久久电影网站| 人人妻人人澡人人爽欧美精品| 国产成人精品无码一区二区| 日韩电影免费在线观看中文字幕| 粉嫩久久99精品久久久久久夜| jk制服| 99精产三产区区别| av无码av天天av天天爽| 人人妻人人澡人人爽人人精品97| 国产在线精品一区二区夜色| 狠狠色婷婷久久综合频道毛片| 北条麻妃在线一区二区| 在线观看亚洲AV无码每日更新 | 亚洲精品**不卡在线播he | 国产清纯在线一区二区| 亚洲丁香婷婷综合久久| 亚洲国产AV无码精品无广告| 精品人妻无码视频一区二区三区| 亚洲国产中文成人无码aV在线| 久久久久久久精品国产亚洲| 国产裸体美女永久免费无遮挡 |